Peripheral BDNF level alterations have been related to impaired cognition in schizophrenia and psychosis, particularly in memory, attention, and executive functioning domains [21], supporting the potential utility of BDNF not only as a pathophysiological marker but also as a biomarker of cognitive outcomes in psychotic disorders [21]. Here, BDNF is linked to schizophrenia.